These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12760193)

  • 1. Antithrombotic therapy for atherosclerotic intracranial arterial stenosis.
    Chimowitz MI
    Adv Neurol; 2003; 92():271-4. PubMed ID: 12760193
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of intracranial atherosclerotic stenosis.
    Turan TN; Chimowitz MI
    Rev Neurol Dis; 2008; 5(3):117-24. PubMed ID: 18838951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10 questions about intracranial atherosclerotic stenosis.
    Turan TN; Chimowitz MI
    Neurologist; 2010 Nov; 16(6):400-5. PubMed ID: 21150394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic alternatives for symptomatic intracranial atherosclerotic disease.
    Cohen JE; Rajz G; Gomori JM; Umansky F
    Isr Med Assoc J; 2003 Oct; 5(10):731-3. PubMed ID: 14719471
    [No Abstract]   [Full Text] [Related]  

  • 5. The contemporary management of intracranial atherosclerotic disease.
    Leng X; Wong KS; Leung TW
    Expert Rev Neurother; 2016 Jun; 16(6):701-9. PubMed ID: 27082149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial atherosclerotic disease: common, dangerous, and treatable.
    Hanel RA; Levy EL; Guterman LR; Hopkins LN
    Clin Neurosurg; 2005; 52():68-75. PubMed ID: 16626056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atherothrombosis: state-of-the-art review and approaches to the problem].
    Bokarev IN; Popova LV
    Klin Med (Mosk); 2008; 86(8):4-12. PubMed ID: 18819339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of intracranial atherosclerosis has been shown to be superior.
    Sila C
    J Neurointerv Surg; 2012 Mar; 4(2):83-4. PubMed ID: 22318262
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic therapy for prevention of recurrent stroke in the new millennium.
    Schneck MJ; Biller J
    Expert Rev Neurother; 2004 Mar; 4(2):145-9. PubMed ID: 15853554
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
    O'Donnell M; Weitz JI
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S72-82. PubMed ID: 15152749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy.
    Stramba-Badiale M
    Eur Heart J; 2008 Apr; 29(7):840-2. PubMed ID: 18334477
    [No Abstract]   [Full Text] [Related]  

  • 13. Current concepts in the management of intracranial atherosclerotic disease.
    Ecker RD; Levy EI; Sauvageau E; Hanel RA; Hopkins LN
    Neurosurgery; 2006 Nov; 59(5 Suppl 3):S210-8; discussion S3-13. PubMed ID: 17053605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
    Vergouwen MD; Vermeulen M; Roos YB
    Neurology; 2009 Apr; 72(16):1447; author reply 1447-8. PubMed ID: 19380708
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mental deterioration in arteriosclerotic subjects before and after treatment with SP 54 and with a placebo].
    Buffa B; Cotta Ramusino M; Muti M
    Riv Sper Freniatr Med Leg Alien Ment; 1969 Feb; 93(1):209-18. PubMed ID: 5402879
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of ischemic stroke secondary to large artery atherosclerotic disease.
    Derdeyn CP
    Neuroimaging Clin N Am; 2007 Aug; 17(3):303-11, vii-viii. PubMed ID: 17826633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Kirmani JF; Hussein HM; Harris-Lane P; Divani AA; Suri MF; Janjua N; Alkawi A
    Neurosurgery; 2006 Nov; 59(5):1044-51; discussion 1051. PubMed ID: 17143239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombotic agents and cerebrovascular prevention: what is new?].
    Bogousslavsky J
    Schweiz Med Wochenschr; 1997 Nov; 127(47):1941-4. PubMed ID: 9480533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 20. A fresh twist on carotid artery dissections.
    Kasner SE; Dreier JP
    Neurology; 2009 May; 72(21):1800-1. PubMed ID: 19321842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.